Quarterly Report

Vanda Pharmaceuticals Inc. Filed 2023-07-28 Acc 0001628280-23-026000

Documents 1

2023-11-09 10-Q Quarterly Report
2023-08-01 4 SVP, CFO & Treasurer sold 2,212 shares at an average $6.30 ($13,945)
2023-07-28 144 Sale of Securities
2023-07-28 10-Q Quarterly Report
2023-07-27 8-K Results of operations
2023-05-03 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading vnda-20230630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…